Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5189571
Max Phase: Preclinical
Molecular Formula: C16H18F3N3O4S
Molecular Weight: 405.40
Associated Items:
ID: ALA5189571
Max Phase: Preclinical
Molecular Formula: C16H18F3N3O4S
Molecular Weight: 405.40
Associated Items:
Canonical SMILES: O=C(CCCCCCC(=O)Nc1nc2ccc(OC(F)(F)F)cc2s1)NO
Standard InChI: InChI=1S/C16H18F3N3O4S/c17-16(18,19)26-10-7-8-11-12(9-10)27-15(20-11)21-13(23)5-3-1-2-4-6-14(24)22-25/h7-9,25H,1-6H2,(H,22,24)(H,20,21,23)
Standard InChI Key: VYQDOPQZKLHMPQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 405.40 | Molecular Weight (Monoisotopic): 405.0970 | AlogP: 3.98 | #Rotatable Bonds: 9 |
Polar Surface Area: 100.55 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.89 | CX Basic pKa: | CX LogP: 4.26 | CX LogD: 4.14 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.33 | Np Likeness Score: -1.55 |
1. Wan Y, Long J, Gao H, Tang Z.. (2021) 2-Aminothiazole: A privileged scaffold for the discovery of anti-cancer agents., 210 [PMID:33148490] [10.1016/j.ejmech.2020.112953] |
Source(1):